Patrick Burnett, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 222 shares at $21.05 ($5K) on 2026-05-11, disclosed to the SEC on 2026-05-13.
Open-market sale of $5k ARQT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ARQT | SELL | 2026-08-05 | $25K | — | Filing → |
| ARQT | SELL | 2026-05-06 | $16K | — | Filing → |
| ARQT | SELL | 2026-03-03 | $317K | — | Filing → |